Legislative Research: US SB4348 | 2021-2022 | 117th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Introduced - Dead) | A bill to amend the Federal Power Act to prohibit the Federal Energy Regulatory Commission from issuing permits for the construction or modification of electric transmission facilities in a State over the objection of the State, and for other purpose... [SB4348 2023 Detail][SB4348 2023 Text][SB4348 2023 Comments] | 2024-05-15 Read twice and referred to the Committee on Energy and Natural Resources. |
| 2021-2022 117th Congress (Introduced - Dead) | A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. [SB4348 2021 Detail][SB4348 2021 Text][SB4348 2021 Comments] | 2022-07-13 Placed on Senate Legislative Calendar under General Orders. Calendar No. 444. |
| 2019-2020 116th Congress (Introduced - Dead) | Requires the Government Accountability Office to conduct a study on access to health care in rural areas during the COVID-19 (i.e., coronavirus disease 2019) emergency. Specifically, this study must evaluate the use of telehealth and the impact of en... [SB4348 2019 Detail][SB4348 2019 Text][SB4348 2019 Comments] | 2020-07-28 Read twice and referred to the Committee on Finance. |
References Online
| Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
|---|---|---|---|---|---|---|---|
| [US Congress SB4348] | Google Web | Google News | |||||
| [Senator Patty Murray US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
| [Senator Richard Burr US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US SB4348 | 2021-2022 | 117th Congress. (2022, July 13). LegiScan. Retrieved January 23, 2025, from https://legiscan.com/US/bill/SB4348/2021
MLA
"US SB4348 | 2021-2022 | 117th Congress." LegiScan. LegiScan LLC, 13 Jul. 2022. Web. 23 Jan. 2025. <https://legiscan.com/US/bill/SB4348/2021>.
Chicago
"US SB4348 | 2021-2022 | 117th Congress." July 13, 2022 LegiScan. Accessed January 23, 2025. https://legiscan.com/US/bill/SB4348/2021.
Turabian
LegiScan. US SB4348 | 2021-2022 | 117th Congress. 13 July 2022. https://legiscan.com/US/bill/SB4348/2021 (accessed January 23, 2025).
Subjects
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| HB7035 | Related | 2022-03-10 | Biologics Market Transparency Act of 2022 | Referred to the Subcommittee on Health. |
| HB7640 | Related | 2022-05-03 | To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs"). | Referred to the House Committee on Energy and Commerce. |
| HB7658 | Related | 2022-05-03 | To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. | Referred to the House Committee on Energy and Commerce. |
| HB7679 | Related | 2022-05-06 | To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes. | Referred to the House Committee on Energy and Commerce. |
| SB2628 | Related | 2021-08-05 | Better ODDS To Reduce Diversion Act of 2021 Better Options for Drug Disposal Systems To Reduce Diversion Act of 2021 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB2952 | Related | 2021-10-07 | FDA Modernization Act of 2021 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4152 | Related | 2022-05-05 | A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4288 | Related | 2022-05-19 | Reducing Animal Testing Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4302 | Related | 2022-05-25 | Biologics Market Transparency Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709) |
| SB4303 | Related | 2022-05-25 | Interchangeable Biologics Clarity Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710) |
| SB4378 | Related | 2022-06-13 | Hatch-Waxman Improvement Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB4446 | Related | 2022-06-22 | Modernizing the Accelerated Approval Pathway Act of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S3077-3078) |
| SB4535 | Related | 2022-07-14 | FDASRA Act of 2022 Food and Drug Administration Simple Reauthorization Act of 2022 Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB5002 | Related | 2022-09-29 | FDA Modernization Act 2.0 | Held at the desk. |
| HB9329 | Related | 2022-11-18 | Small Business Establishment Registration Waiver Act | Referred to the Subcommittee on Health. |
